Spots Global Cancer Trial Database for An Open-Label Safety Study of A-101 Solution

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Open-Label Safety Study of A-101 Solution

Official Title: An Open-Label Study of the Safety of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face.

Study ID: NCT02667288

Conditions

Seborrheic Keratosis

Interventions

A-101 Solution

Study Description

Brief Summary: This is an open-label safety study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face.

Detailed Description: This is an open-label safety study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face. The Target Lesions will be treated a maximum of 4 times.